Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No

Journal article

Peer reviewed

The Journal of urology, Vol.198(2), pp.266-267

2017-08

PMID: 28629663

Abstract

Risk Assessment - methods

Prognosis

Humans

Precision Medicine - economics

Gene Expression Profiling - economics

Male

Genetic Testing - methods

Patient Selection

Prostatic Neoplasms - therapy

Prostate - pathology

Risk Assessment - economics

Prostatic Neoplasms - genetics

Biomarkers, Tumor - urine

Biopsy - economics

Prostatic Neoplasms - pathology

Gene Expression Profiling - methods

Treatment Outcome

Neoplasm Recurrence, Local - diagnosis

Clinical Decision-Making - methods

Biomarkers, Tumor - blood

Health Care Costs

Neoplasm Recurrence, Local - genetics

Watchful Waiting

Biomarkers, Tumor - genetics

Genetic Testing - economics

Precision Medicine - methods

4 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.97 Prostate Cancer
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No
Creators: Sanoj Punnen - Department of Urology, University of Miami Miller School of Medicine, Miami, Florida
Dipen J Parekh - Department of Urology, University of Miami Miller School of Medicine, Miami, Florida
Publication Details: The Journal of urology, Vol.198(2), pp.266-267
Publisher: United States
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Department of Urology
Language: English
Resource Type: Journal article
PMID: 28629663
Record Identifier: 991031576321602976